JavaScript is disabled for your browser. Some features of this site may not work without it.
Get the latest COVID-19 technical guidance, scientific and policy briefs here.✕
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

PAHO IRIS

Evaluation of specific biochemical indicators of Helicobactepylori-associated gastric cancer in Egypt

Thumbnail
View/Open
18_5_2012_0501_0507.pdf (‎272.4Kb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
  • CSV
  • Excel
  • BibTeX
  • RIS
Abstract
The aim of the study was to assess the accuracy of some specific biochemical indicators in discriminating between Helicobacter pylori-associated gastritis and H. pylori-associated stomach cancer [‎serum gastrin level, serum soluble E-cadherin and tissue COX-2 activity, as well as serodiagnostic markers for H. pylori infection]‎ in order to find a simple diagnostic test that can reasonably predict the development of gastric cancer. The study participants comprised 20 patients with gastric carcinoma, 20 patients with positive H. pylori-associated gastritis and 20 individuals as the control group. Standard procedures and quality control measures were followed. Using cut-off values and ROC analysis to assess the diagnostic abilities of the biochemical indicators, E-cadherin showed the highest sensitivity [‎100%]‎. We suggest that close follow-up together with periodic endoscopic examination for all patients with persistent H. pylori infection and serum soluble E-cadherin level above 5 microg/mL is essential
Citation
Anwar, M.M., Youssef, A.I., Sheta, M.I., Zaki, A., Bernaba, N.R. et al. (‎2012)‎. Evaluation of specific biochemical indicators of Helicobactepylori-associated gastric cancer in Egypt. EMHJ - Eastern Mediterranean Health Journal, 18 (‎5)‎, 501-507, 2012 https://apps.who.int/iris/handle/10665/118268
Journal
EMHJ - Eastern Mediterranean Health Journal, 18 (‎5)‎, 501-507, 2012
Description
501-507
ISSN
1020-3397
Other Identifiers
http://applications.emro.who.int/emhj/v18/05/18_5_2012_0501_0507.pdf
Language
English
Collections
  • EMRO Journal Articles (‎EMHJ)‎
Metadata
Show full item record

Show Statistical Information

View Item 
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item

© 2021 WHO